0001883067-21-000001.txt : 20210923 0001883067-21-000001.hdr.sgml : 20210923 20210923132319 ACCESSION NUMBER: 0001883067-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210923 DATE AS OF CHANGE: 20210923 EFFECTIVENESS DATE: 20210923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Affect Therapeutics, Inc. CENTRAL INDEX KEY: 0001883067 IRS NUMBER: 852224169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-414392 FILM NUMBER: 211271985 BUSINESS ADDRESS: STREET 1: 520 BROADWAY, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10012 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 520 BROADWAY, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10012 D 1 primary_doc.xml X0708 D LIVE 0001883067 Affect Therapeutics, Inc. 520 BROADWAY, 4TH FLOOR NEW YORK NY NEW YORK 10012 929-552-2849 DELAWARE None None Corporation true 2020 Kristin Muhlner c/o Affect Therapeutics, Inc. 520 Broadway, 4th Floor New York NY NEW YORK 10012 Executive Officer Director Jeff DeFlavio c/o Affect Therapeutics, Inc. 520 Broadway, 4th Floor New York NY NEW YORK 10012 Director Kevin Ryan c/o Affect Therapeutics, Inc. 520 Broadway, 4th Floor New York NY NEW YORK 10012 Director Jeff Rinehart c/o Affect Therapeutics, Inc. 520 Broadway, 4th Floor New York NY NEW YORK 10012 Director Other Decline to Disclose 06b false 2021-06-23 false true false 0 6504278 6504278 0 The total amount sold includes convertible notes and the securities issuable hereto. false 10 0 0 0 false Affect Therapeutics, Inc. /s/ Kristin Muhlner Kristin Muhlner Chief Executive Officer 2021-09-23